| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E. coli-derived zebrafish Dnm1a/b recombinant protein (amino acids G614-D666) was used as the immunogen for the Zebrafish Dnm1 antibody. This antibody will detect the a & b isoforms. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
Zebrafish Dnm1 Antibody / Dnm1a / Dnm1b / Dynamin is a anti-DNM1 Rabbit antibody Polyclonal (rabbit origin) supplied in Antigen affinity purified format. Recommended for workflows such as Immunofluorescence (IF), IHC-P with listed reactivity in Zebrafish. Reported localization: Cytoplasm.
Key elements and design rationale
- Target: DNM1
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit Ig
- Format: Antigen affinity purified
- Applications (as listed): IF, IHC-P
Biological background
Zebrafish express multiple dnm1 transcript variants that give rise to isoform a and isoform b, which may differ in their tissue distribution, regulatory elements, or functional properties. Both isoforms contribute to the dynamic regulation of synaptic membranes but may be expressed at different developmental stages or in distinct neuronal populations.
Dnm1 isoform a is typically expressed during early neural development and is enriched in regions of the brain with high synaptic activity. It supports the rapid and repeated cycles of vesicle fission that are essential for sustained neurotransmitter release.
Dnm1 isoform b may have overlapping or complementary roles to isoform a, potentially contributing to synaptic maintenance or plasticity in mature neurons. It may also be involved in neural differentiation and axonal growth during zebrafish development.
Because of its essential function in synaptic physiology, zebrafish Dnm1 is a widely used model for studying neural development, synaptic transmission, and neurological disorders associated with defects in vesicle recycling. It is particularly valuable in research on seizure susceptibility and developmental brain disorders, where Dnm1 mutations are known to have pathogenic effects in other vertebrates.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Immunofluorescence: visualize subcellular distribution and cell-to-cell heterogeneity.
- Immunohistochemistry: map target signal in tissue context and compare regions/phenotypes.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
